DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Bonderman D, Ghio S, Felix SB et al.
Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study.
Circulation 2013;
128: 502-511
We do not assume any responsibility for the contents of the web pages of other providers.